By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


OXiGENE, Inc. 

230 Third Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-547-5900 Fax: 781-547-6800



Company News
OXiGENE (OXGN) Announces Participation In Upcoming Investor And Medical Conferences 4/3/2015 7:16:10 AM
OXiGENE (OXGN) Announces $10 Million At-the-Market Registered Direct Offering 3/20/2015 7:22:54 AM
OXiGENE (OXGN) Reports Financial Results For 2014 3/18/2015 7:41:42 AM
OXiGENE (OXGN) Announces 2014 Financial Results Conference Call And Webcast 3/5/2015 7:37:00 AM
OXiGENE (OXGN) Announces Presentation And Webcast At The 27th Annual ROTH Conference On March 11th 2/24/2015 10:24:32 AM
OXiGENE (OXGN) Announces Presentation And Webcast At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference On February 10th 1/27/2015 7:31:34 AM
OXiGENE (OXGN) Announces Preclinical Poster Presentation On Oxi4503 At Upcoming American Society of Hematology Meeting 11/20/2014 2:17:32 PM
OXiGENE (OXGN) Announces Issuance Of European Patent for OXi4503 In Acute Myeloid Leukemia And Other Myeloid Malignancies 11/17/2014 2:43:50 PM
OXiGENE (OXGN) Reports Third Quarter 2014 Financial Results 11/13/2014 8:08:46 AM
OXiGENE (OXGN) Announces Presentation Of Phase 2 Data Confirming That Addition Of Fosbretabulin To Bevacizumab Significantly Increases Progression-Free Survival In Recurrent Ovarian Cancer 11/10/2014 7:24:44 AM